Lithuania's Invalda to sell its Sanitas stake
This article was originally published in Scrip
Executive Summary
Invalda, a Lithuanian investment firm specialising in pharmaceuticals, among other fields, and operating in central and eastern Europe, is selling a 20% stake in Sanitasto Baltic Pharma, a firm linked to Citigroup Venture Capital International Jersey (CVCIJ), a private investor in growing markets, for €30 million.